Latest Payments News

The GPT Group has reported a remarkable financial turnaround for FY2025, posting a 264% increase in total revenues and declaring a 12 cent distribution per stapled security. This strong performance signals renewed confidence in the property trust’s operational strategy.

Neometals Ltd has resolved a longstanding legal dispute with a $1 million settlement, clearing the way to focus on advancing its Barrambie Gold Project and sustainable processing technologies.

BTC Health’s investee, BTC Cardio, has landed exclusive Australian distribution rights for Jafron Biomedical’s hemoperfusion cartridges, aiming for a 2026 market debut pending regulatory approval.

WCM Global Growth Limited reported a net operating profit of $22.9 million for H1 FY2026 and announced an increased fully franked interim dividend, reinforcing its progressive dividend policy.

WCM Global Growth Limited reported a 51% drop in net profit for H1 FY2026 but announced an increased fully franked interim dividend, reflecting confidence in its investment strategy. The company’s portfolio outperformed its benchmark over 12 months despite a softer half-year return.

Katana Capital Limited has reported a remarkable 672% increase in half-year profit after tax to $5.8 million, driven by strong investment income and gains. The company maintains its quarterly dividend at 0.5 cents per share, reflecting confidence in its ongoing strategy.

ResMed Inc has updated the foreign exchange rate for its upcoming dividend payment to Australian CDI holders, impacting the Australian dollar amount payable per share. The dividend remains unfranked and subject to US withholding tax, with a reduced rate available under the US-Australia tax treaty.

Advance ZincTek Limited has confirmed a shareholder-approved capital return of 2 cents per share, distributing approximately A$1.252 million back to investors. Payment instructions have been issued ahead of the scheduled February payout.

Ovanti Limited has completed a $1.08 million capital raise through a large share placement aimed at funding its growing U.S. buy now, pay later business and global operations.

AVITA Medical reported a mixed fourth quarter with revenue pressures easing and full-year growth, underpinned by a new $60 million credit facility and advancing clinical trials.

Regal Asian Investments has announced a fully franked interim dividend of 8 cents per share, reflecting robust portfolio returns exceeding 30% over six months. The company also updates its dividend policy to focus on sustainable payouts tied to investment performance.

AVITA Medical closed 2025 with steady revenue growth and over 80% gross margin, setting the stage for a confident revenue forecast of up to US$85 million in 2026. The company also secured a new debt facility with improved terms, underpinning its growth ambitions.